AgingResearch.NewsJoin free

Relaxin 3

Relaxin 3 has been studied in 1 paper since 2022: none in people yet, 1 review. No study of it in people or animals has been published yet. The newest paper, Apr 15, 2022: “The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease”.

Intervention

1 paper studies it1 findingUpdated

More peptides

What did studies of Relaxin 3 find?

1

Studies of Relaxin 3 measured 1 outcome; the most studied are DNA damage response (1 study).

DNA damage response

upin reviews1

1 study

  1. Relaxin 3 activates DNA damage response.

    “Overexpression or stimulation of this receptor, by its endogenous ligand relaxin 3 (RLN3), can regulate the DNA damage response and repair processes.”

    Reviewby its endogenous ligand relaxin 3 (RLN3)

    The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease

    International journal of molecular sciences

More on DNA damage response

Latest

Related